about
Inflammation converts human mesoangioblasts into targets of alloreactive immune responses: implications for allogeneic cell therapy of DMDPartial dysferlin reconstitution by adult murine mesoangioblasts is sufficient for full functional recovery in a murine model of dysferlinopathy.Stem cell transplantation for muscular dystrophy: the challenge of immune response.PW1/Peg3 expression regulates key properties that determine mesoangioblast stem cell competence.Intra-arterial transplantation of HLA-matched donor mesoangioblasts in Duchenne muscular dystrophy.piggyBac transposons expressing full-length human dystrophin enable genetic correction of dystrophic mesoangioblasts.Ret function in muscle stem cells points to tyrosine kinase inhibitor therapy for facioscapulohumeral muscular dystrophy.Targeting endothelial junctional adhesion molecule-A/ EPAC/ Rap-1 axis as a novel strategy to increase stem cell engraftment in dystrophic muscles.Human artificial chromosomes for Duchenne muscular dystrophy and beyond: challenges and hopes.Pluripotent Stem Cells for Gene Therapy of Degenerative Muscle Diseases.Enhanced Energetic State and Protection from Oxidative Stress in Human Myoblasts Overexpressing BMI1.Muscle Interstitial Cells: A Brief Field Guide to Non-satellite Cell Populations in Skeletal Muscle.Transplantation of induced pluripotent stem cell-derived mesoangioblast-like myogenic progenitors in mouse models of muscle regeneration.Globular adiponectin as a complete mesoangioblast regulator: role in proliferation, survival, motility, and skeletal muscle differentiation.Stem cell-mediated transfer of a human artificial chromosome ameliorates muscular dystrophy.Collagen VI regulates satellite cell self-renewal and muscle regeneration.Transplantation of genetically corrected human iPSC-derived progenitors in mice with limb-girdle muscular dystrophy.Reversible immortalisation enables genetic correction of human muscle progenitors and engineering of next-generation human artificial chromosomes for Duchenne muscular dystrophy.Efficient derivation and inducible differentiation of expandable skeletal myogenic cells from human ES and patient-specific iPS cells.Skeletal Muscle Differentiation on a Chip Shows Human Donor Mesoangioblasts' Efficiency in Restoring Dystrophin in a Duchenne Muscular Dystrophy Model.Three-Dimensional Human iPSC-Derived Artificial Skeletal Muscles Model Muscular Dystrophies and Enable Multilineage Tissue Engineering.Intra-arterial transplantation of HLA-matched donor mesoangioblasts in Duchenne muscular dystrophy.Modeling Skeletal Muscle Laminopathies Using Human Induced Pluripotent Stem Cells Carrying Pathogenic MutationsErratum: Corrigendum: Efficient derivation and inducible differentiation of expandable skeletal myogenic cells from human ES and patient-specific iPS cellsCombined Notch and PDGF Signaling Enhances Migration and Expression of Stem Cell Markers while Inducing Perivascular Cell Features in Muscle Satellite CellsEfficient CRISPR/Cas9-mediated editing of trinucleotide repeat expansion in myotonic dystrophy patient-derived iPS and myogenic cells.Generation of two genomic-integration-free DMD iPSC lines with mutations affecting all dystrophin isoforms and potentially amenable to exon-skippingPericytes in Muscular DystrophiesChallenging the "chromatin hypothesis" of cardiac laminopathies with LMNA mutant iPS cellsStem cell culture conditions and stability: a joint workshop of the PluriMes Consortium and Pluripotent Stem Cell Platform
P50
Q28389778-07BE9574-1643-49D3-B47D-7E68E0480732Q33833512-F88370C0-B486-4C69-838D-760F52012619Q33902416-110BBF5F-AAB3-4C74-9397-61B21DFD3E3BQ35197078-4A0ED93C-5D59-4DC3-9935-B1E3DFD2D201Q36410147-AABB5229-C893-46DE-9092-0AFC25155F58Q36532676-501373CC-256F-42C6-B2FB-7ED4D433EB0AQ37413081-5A685E4D-D17F-47F7-967F-652BFC76276FQ37591115-80F12E36-BE9C-4396-896E-9A391D8B2C2FQ38321965-EA3CD017-71F9-4AE0-8F9C-42158F83C4E4Q38539939-1758A5FD-5843-4C2F-989D-DF4937FFEDF9Q38666009-F8224AB9-755C-4C94-B3A1-1A31CAFA7E1BQ39155795-C31F6796-C89B-4CBA-855B-6A368C611252Q39261708-06A0FE38-CD39-412B-9EDE-E6C4E84F819DQ39570584-267F697A-E985-4474-A770-482659E5B698Q39716553-038E6E04-2862-455E-A865-C8BA85ADD4C3Q42155619-113AD8A8-9BB6-472F-9125-0CE0AE86380FQ42819955-43DC7F44-E596-405B-83A9-B59766A4AD07Q45875854-4732E987-8D9D-4388-A0AC-E5C7CAD8E3CCQ45876520-0562BB0A-050D-4245-B8D3-5477CAEADF2DQ46190014-B279B7D9-0C00-4B37-97FE-BC65B43AD2FDQ52317296-D1B1AA7F-48C4-4E72-8093-D1B10EE7C4FCQ54519313-62A86AB7-3BFC-425B-B823-15AE88699DDDQ58562640-FF8B3F99-57C5-423F-9F84-42F006F478C6Q59204075-1AF0A266-8B4E-4B4D-9E3E-26648E800285Q64249266-392F444F-CD98-42B4-92DA-8C4C31920BDCQ64947331-D2B91CEA-E5D4-4807-88EC-0F4E9A7D8C85Q89841793-3BEAD13E-54D6-4D47-881B-3696C40BB10EQ92421314-E663F36D-9ADA-402F-8627-D7A575C58E5DQ92708260-496BD733-7948-4B3F-988B-E98331EE9282Q92779900-5C5555F4-541E-4063-A67F-EF2D7AC0E9E0
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Francesco Saverio Tedesco
@ast
Francesco Saverio Tedesco
@en
Francesco Saverio Tedesco
@es
Francesco Saverio Tedesco
@nl
Francesco Saverio Tedesco
@sl
type
label
Francesco Saverio Tedesco
@ast
Francesco Saverio Tedesco
@en
Francesco Saverio Tedesco
@es
Francesco Saverio Tedesco
@nl
Francesco Saverio Tedesco
@sl
altLabel
Saverio Tedesco
@en
prefLabel
Francesco Saverio Tedesco
@ast
Francesco Saverio Tedesco
@en
Francesco Saverio Tedesco
@es
Francesco Saverio Tedesco
@nl
Francesco Saverio Tedesco
@sl
P106
P21
P31
P496
0000-0001-5321-7682